Clinical Trial Update: Study of the Safety and Immunogenicity of Reduced Doses of the US Yellow Fever Vaccine [Phase 4]

View source ↗

Summary

Phase 4 study evaluating safety and immunogenicity of reduced doses of the US yellow fever vaccine; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Yellow Fever

Drugs mentioned

• YF-VAX (Yellow fever vaccine live)

Snippet

Sponsor: US Army Medical Research Institute of Infectious Diseases | Conditions: Yellow Fever Vaccination Reaction | Phase 4 | Status: COMPLETED | Results posted: 2026-04-07